- Home
- LGND vs CROX Comparison
LGND vs CROX Comparison
Compare LGND & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGND | CROX |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.8B |
| IPO Year | 1997 | 2005 |
Fundamental Metrics
Financial Performance| Metric | LGND | CROX |
|---|---|---|
| Price | $307.47 | $119.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | ★ $344.25 | $138.75 |
| AVG Volume (30 Days) | 195.5K | ★ 904.9K |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2886.36 | N/A |
| EPS | 1.63 | ★ 6.83 |
| Revenue | $141,102,000.00 | ★ $4,040,647,000.00 |
| Revenue This Year | $8.04 | $1.43 |
| Revenue Next Year | $31.71 | $2.40 |
| P/E Ratio | $189.15 | ★ $17.79 |
| Revenue Growth | ★ 29.48 | N/A |
| 52 Week Low | $175.89 | $73.21 |
| 52 Week High | $326.63 | $141.28 |
Technical Indicators
Market Signals| Indicator | LGND | CROX |
|---|---|---|
| Relative Strength Index (RSI) | 56.77 | 50.34 |
| Support Level | $277.97 | $118.62 |
| Resistance Level | $315.53 | $128.51 |
| Average True Range (ATR) | 10.35 | 3.42 |
| MACD | -0.11 | 0.45 |
| Stochastic Oscillator | 78.61 | 46.36 |
Price Performance
Historical ComparisonAbout LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable operating segments of the company are the Crocs Brand and the HEYDUDE Brand. The company derives maximum revenue from the Crocs brand segment.